Controlled-release Formulation Analysis
Controlled-Release Formulation Analysis is a pharmaceutical analytical methodology that characterizes the kinetics and mechanisms of drug release from dosage forms designed to sustain or modulate delivery over an extended period, distinguishing it from immediate-release formulation analyses by its focus on temporal control and release profile predictability.
100
Publications
3.4K
Citations
452
Authors
150
Institutions
Publications per year
2017–2026
11
Parents
100
Philip Van Kerrebroeck, A Jardin, K.U. Laval et al. · European Urology · 2000 · 150 citations
Francesca Ungaro, Giuseppe De Rosa, Agnese Miro et al. · Journal of Pharmaceutical and Biomedical Analysis · 2003 · 105 citations
1–5 of 100
452
4
h-index
2
h-index
2
h-index
2
h-index
2
h-index
1–5 of 452
150

University of Nottingham
Nottingham, United Kingdom
4 h-index
7 publications
175 citations

Ghent University
Ghent, Belgium
2 h-index
4 publications
110 citations
Advanced Science Research Center
Naka, Japan
2 h-index
13 publications
593 citations
Osaka University of Pharmaceutical Sciences
Takatsuki, Japan
2 h-index
5 publications
392 citations

University of Mississippi
Oxford, United States
2 h-index
10 publications
264 citations

Monsanto (United States)
Creve Coeur, United States
2 h-index
9 publications
297 citations
Université de Montréal
Montreal, Canada
2 h-index
4 publications
116 citations
Queen's Medical Centre
Nottingham, United Kingdom
2 h-index
4 publications
68 citations
1–8 of 150
25 publications · 1K citations
19
h-index
9 publications · 356 citations
9
h-index
6 publications · 317 citations
6
h-index
5 publications · 252 citations
5
h-index
4 publications · 163 citations
4
h-index
1–5